Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7330 p877
18/25 December 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Parasitic worms benefit Crohn’s disease patients

Parasitic worms may be a safe and effective treatment for Crohn’s disease, new research suggests.

In an open label study 29 patients with active Crohn’s disease ingested a drink containing 2,500 eggs of the helminth Trichuris suis every three weeks for 24 weeks. The eggs had been treated so that they would not transfer any bacteria or viruses to the study participants. Patients continued to take their regular medicines at the dose they had been stabilised on and their symptoms were recorded using a disease activity score. After 24 weeks, nearly 80 per cent of patients (23) experienced an improvement in their condition and over 72 per cent (21) went into remission.

Crohn’s disease is less common in less developed areas of the world where most people carry worms, and worms have previously been shown to reduce inflammation in mouse models of colitis. The researchers describe how Crohn’s disease is associated with over reactive type 1 T-helper cell pathways and say that helminths inhibit these immune responses.

They add that although a high placebo effect cannot be excluded, no side effects or complications were reported from the treatment and helminths may therefore offer an alternative or supplement to current treatments. They say that these results justify further research (Gut 2005;54:87).

Back to Top


©The Pharmaceutical Journal